We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Keros Therapeutics
KROS
$199M
| $1.02M | ﹤0.01% |
22,377
-250,594
| -92% | -$13.5M |
|
1652
INmune Bio
INMB
$45.5M
| $1.02M | ﹤0.01% |
115,916
+89,091
| +332% | +$878K |
|
1653
Stanley Black & Decker
SWK
$14.7B
| $1.02M | ﹤0.01% |
+12,767
| New | +$1.12M |
|
1654
SIGA Technologies
SIGA
$235M
| $1.02M | ﹤0.01% |
134,285
-234,239
| -64% | -$1.91M |
|
1655
Zurn Elkay Water Solutions
ZWS
$8.21B
| $1.02M | ﹤0.01% |
+34,652
| New | +$1.09M |
|
1656
Inogen
INGN
$174M
| $1.02M | ﹤0.01% |
125,205
-204,107
| -62% | -$1.58M |
|
1657
Virtus Investment Partners
VRTS
$1.15B
| $1.02M | ﹤0.01% |
4,498
-3,815
| -46% | -$868K |
|
|
TDAY
1658
USA Today Co
TDAY
$1.26B
| $1.02M | ﹤0.01% |
220,206
+104,795
| +91% | +$351K |
|
1659
Pediatrix Medical
MD
$2.2B
| $1.01M | ﹤0.01% |
134,191
+83,082
| +163% | +$687K |
|
1660
Frontier Group Holdings
ULCC
$1.43B
| $1.01M | ﹤0.01% |
+205,049
| New | +$1.23M |
|
1661
Cognyte Software
CGNT
$656M
| $1M | ﹤0.01% |
131,430
-120,817
| -48% | -$903K |
|
|
HAYN
1662
DELISTED
Haynes International, Inc.
HAYN
| $1M | ﹤0.01% |
17,100
-12,300
| -42% | -$731K |
|
1663
Quanta Services
PWR
$88.3B
| $1M | ﹤0.01% |
3,938
-17,000
| -81% | -$4.5M |
|
1664
Huntington Bancshares
HBAN
$34.9B
| $992K | ﹤0.01% |
+75,279
| New | +$1.01M |
|
1665
World Acceptance Corp
WRLD
$871M
| $992K | ﹤0.01% |
8,025
+3,771
| +89% | +$497K |
|
1666
Transcat
TRNS
$806M
| $989K | ﹤0.01% |
8,267
+3,080
| +59% | +$364K |
|
1667
AMERISAFE
AMSF
$571M
| $989K | ﹤0.01% |
+22,523
| New | +$1.03M |
|
1668
Nomura Holdings
NMR
$28.1B
| $988K | ﹤0.01% |
+170,907
| New | +$1.01M |
|
1669
Autohome
ATHM
$2.64B
| $986K | ﹤0.01% |
35,919
-1,021
| -3% | -$27.7K |
|
|
DHIL
1670
DELISTED
Diamond Hill
DHIL
| $980K | ﹤0.01% |
6,966
+328
| +5% | +$49.3K |
|
1671
Safety Insurance
SAFT
$1.51B
| $980K | ﹤0.01% |
+13,061
| New | +$1.03M |
|
|
PLYM
1672
DELISTED
Plymouth Industrial REIT
PLYM
| $978K | ﹤0.01% |
+45,736
| New | +$959K |
|
1673
Mayville Engineering Co
MEC
$703M
| $978K | ﹤0.01% |
+58,686
| New | +$887K |
|
1674
Global X MLP & Energy Infrastructure ETF
MLPX
$3.57B
| $976K | ﹤0.01% |
19,122
+3,483
| +22% | +$172K |
|
1675
IDT Corp
IDT
$1.68B
| $976K | ﹤0.01% |
+27,167
| New | +$1.02M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.